Current Impactful Studies: Difference between revisions
Richardpruen (talk | contribs) |
Richardpruen (talk | contribs) |
||
| Line 63: | Line 63: | ||
==[https://pubmed.ncbi.nlm.nih.gov/33241632/ Commentary on Notley et al. (2020): Understanding transitions in the use of nicotine and tobacco products-the value of qualitative longitudinal research]== | ==[https://pubmed.ncbi.nlm.nih.gov/33241632/ Commentary on Notley et al. (2020): Understanding transitions in the use of nicotine and tobacco products-the value of qualitative longitudinal research]== | ||
*Qualitative longitudinal research is an underused methodology in addiction research, but can provide valuable insights into transitions in the use of addictive substances, including e‐cigarettes and tobacco smoking. | |||
==[https://pubmed.ncbi.nlm.nih.gov/33252049/ impact of lung diseases, smoking and e-cigarette use on the severity of COVID-19 illness at diagnosis]== | ==[https://pubmed.ncbi.nlm.nih.gov/33252049/ impact of lung diseases, smoking and e-cigarette use on the severity of COVID-19 illness at diagnosis]== | ||